|
Generation of Vaccines Preventing the Common Cold
Application
A new class of vaccines targeting the viruses causing the common cold, rhinoviruses (RV).
Key Benefits
Capsid-chimeric strains for developing new RV vaccines.
Preclinical data with a prototype show the ability to induce a robust capsid-specific immune response.
Straightforward and inexpensive vaccine manufacturing process utilizing...
Published: 2/13/2025
Contributor(s): Sujin Lee
|
